PARSIPPANY, N.J.–(BUSINESS WIRE)–Iveric Bio announced that it has entered into a term loan debt financing facility with Hercules Capital, Inc. and Silicon Valley Bank.
Author: Business Wire
Versant Health Names Rachel Pokay Head of Brand Activation and Market Enablement
BALTIMORE–(BUSINESS WIRE)– #avp–AVP Rachel Pokay brings diverse Marketing Communications experience to Versant Health
AcuFocus Announces FDA Approval for the IC-8® Apthera™ Intraocular Lens, the First and Only Small Aperture Lens for Cataract Surgery
IRVINE, Calif.–(BUSINESS WIRE)–AcuFocus, Inc., a privately held ophthalmic medical device company, today announced U.S. Food and Drug Administration (FDA) approval for its breakthrough IC-8® Apthera™ intraocular lens (IOL) for the treatment of catara…
Ocular Therapeutix™ To Report Second Quarter 2022 Financial Results
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today a…
Palm Medical Centers’ Dr. Robert Barbarite awarded “Best Doctor” for the 14th Consecutive Year
CORAL GABLES, Fla.–(BUSINESS WIRE)–Palm Medical Centers’ Dr. Robert Barbarite awarded “Best Doctor” for the 14th Consecutive Year
Warby Parker to Announce Second Quarter 2022 Financial Results on August 11, 2022
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE: WRBY) (the “Company”), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the second quarter of 2022 will be released before market open on …
Age-related Macular Degeneration (AMD) Market Insight, Epidemiology and Market Forecasts, 2019-2022 & 2022-2032 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Age-related Macular Degeneration (AMD) – Market Insight, Epidemiology And Market Forecast – 2032” report has been added to ResearchAndMarkets.com’s offering. This ‘Age-related Macular Degeneration (AMD)-Market Insights, Ep…
NovaBay Pharmaceuticals’ DERMAdoctor Products Now Available at Target.com and Urbanoutfitters.com
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and skincare products, announces the availability of selec…
Wellspring Ophthalmics Announces Receiving Its Second Patent for Novel Cyclosporine Dry Eye Therapy
MISSION VIEJO, Calif.–(BUSINESS WIRE)–Today, Wellspring Ophthalmics, a Mission Viejo-based development stage eye care pharmaceutical company focused on innovating an improved, effective dry eye therapy, announces receiving its second patent for a nov…
National Vision Supports National Optometric Student Association Members With $7,000 in Scholarships
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE), one of the nation’s largest optical retailers providing quality, affordable eye care and eyewear, announced the winners of its 2022 National Optometric Student Association (NOS…
ProtoKinetix Successfully Completes Phase 1 Clinical Trials for the Treatment of Type 1 Diabetes in Islet Cell Transplants
MARIETTA, Ohio–(BUSINESS WIRE)—- $PKTX #AMD–ProtoKinetix Successfully Completes Phase 1 Clinical Trials for the Treatment of Type 1 Diabetes in Islet Cell Transplants
STAAR Surgical to Report Second Quarter Results on August 10, 2022
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the…
Global Minimally Invasive Glaucoma Surgery Devices Market (2022 to 2027) – Featuring Alcon, Allergan, Carl-Zeiss and Lumenis Among Others – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market (2022-2027) by Target, Surgery, Product, End User, Geography, Competitive Analysis, and the Impact of Covid-19 with Ansoff Analysis” report has been added to…
Global Artificial Cornea & Corneal Implant Market Research Report to 2027 – Featuring Bayer, Cornea Biosciences and CorneaGen Among Others – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Artificial Cornea & Corneal Implant Market Research Report by Type (Artificial Cornea and Human Cornea), Disease Indication, Transplant Type, End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Afri…
Avista Therapeutics Partners with Roche to Develop Next-Generation AAV Gene Therapy Vectors for Ocular Diseases
PITTSBURGH–(BUSINESS WIRE)–Avista today announced a partnership with Roche to develop novel AAV gene therapy vectors for the eyes.
$4.86 Bn Eye Tracking Markets by Type, Application, and Industry Vertical – Global Opportunity Analysis and Industry Forecast, 2022-2030 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Eye Tracking Market by Type, Application, and Industry Vertical – Global Opportunity Analysis and Industry Forecast, 2022-2030” report has been added to ResearchAndMarkets.com’s offering. The Global Eye Tracking Market was…
KalVista Pharmaceuticals to Present at 1st Annual H.C. Wainwright Hereditary Angioedema Conference
CAMBRIDGE, Mass. & SALISBURY, England–(BUSINESS WIRE)—- $KALV–KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhib…
The Worldwide Near-Eye Display Industry is Expected to Reach $22.3 Billion by 2027 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Near-Eye Display Market Research Report by Technology, Device Type, Application, Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Near…
Second Sight Medical Products Announces Year Four NIH Funding of its Orion Study
LOS ANGELES–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable visual prostheses that are intended to create an artificial form of useful vision for blind individua…
Iveric Bio Announces Post-Hoc Analysis from GATHER1 Clinical Trial of Zimura® at American Society of Retina Specialists Meeting
PARSIPPANY, N.J.–(BUSINESS WIRE)–Iveric presented results from a post-hoc analysis from the GATHER1 clinical trial of Zimura at American Society of Retina Specialists Meeting.